Kura Investors

Investor Home

Webcast ImageWebcast
Kura Oncology Inc at Oppenheimer 27th Annual Healthcare Conference (Replay)
03/21/17 at 1:35 p.m. ET
Kura Oncology Inc at Oppenheimer 27th Annual Healthcare Conference
Tuesday, March 21, 2017 1:35 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
We are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. Our development programs target cancers with high unmet need, including head and neck, lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias.
Recent Newsmore >
Kura Oncology Reports Fourth Quarter and Full Year 2016 Operational and Financial Results
Kura Oncology to Report Fourth Quarter and Full Year 2016 Financial Results
Kura Oncology Reports Updated Clinical Activity Data in Ongoing Phase 2 Trial for Tipifarnib
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Kura Oncology Inc posts new information to the site. Just enter your e-mail address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed.